A quinazoline derivative which is an alpha-1-selective adrenoceptor blocking agent used on once-a-day basis for therapy of mild-to-moderate hypertension. Terazosin is indicated for the treatment of symptomatic benign prostatic hyperplasia (BPH). Reference standards of Terazosin API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => (4-Nitrosopiperazin-1-yl)(tetrahydrofuran-2-yl)methanone [catalogue_number] => PA 20 3061000 [category_ids] => ,70,75,76,78,82,162, [chemical_name] => [weight] => 213.24 [form] => C9H15N3O3 [cas] => 2470438-57-2 [pslug] => 2470438-57-2-4-nitrosopiperazin-1-yl-tetrahydrofuran-2-yl-methanone-pa203061000 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 20 3061000
CAS :
Molecular Formula : C9H15N3O3
Molecular Weight : 213.24
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
